Managing Director and Chief Executive Officer
Craig Newton has over 30 years’ experience in senior business and operational roles in the medical device, pharmaceutical and biotech sectors, among large companies and small start-ups, with activity in Australasia, Asia and Europe.
His experience encompasses leadership, marketing, operations and project management across diverse therapeutic areas, including oncology, haematology, cell therapies, fertility and cardiovascular disease. Craig has worked at VivaZome Therapeutics, CSL, Serono UK, Bio Nova International, AVAX Australia and Cryptome Pharmaceuticals, in roles such as Executive Director, Chief Operating Officer, Sales and Marketing Director and Business Unit Manager. Prior to his appointment as MD, and CEO, Craig was the Chief Operating Officer at Invion from April 2018 to October 2019. Craig has a Science degree and post-graduate qualifications in Management and in Marketing.
Alex is an Applied Physicist-Mathematician BSc(Hons) with over 35 years experience in the research and development, manufacturing and commercialisation of scientific instrumentation.
Alex has worked on research, analytical, forensic and medical devices, including ISO:9001 and ISO:13485 certifications for forensic and medical light source manufacturing. Alex was General Manager of Forensic Light Sources for Rofin Australia Pty Ltd which won the Australian Small to Medium Business Export Award in 2005. Alex also managed a 3 year Medical Light Source trial for PDT treatment of skin cancers at the Peter McCallum Cancer Centre, resulting in medical device certification for Australia and Europe in 2011. He has presented many international papers and seminars on light sources around the world.
Alex has been a Technical Adviser to Invion on PDT light sources since September 2018.